Penumbra (NYSE:PEN) announced today that it completed enrollment in the STORM-PE trial of its Lightning Flash system. STORM-PE evaluates Lightning Flash computer-assisted vacuum thrombectomy (CAVT) plus anticoagulation. It pits that against anticoagulation alone in the treatment of acute intermediate-high risk pulmonary embolism (PE). The study … [Read more...] about Penumbra completes enrollment in pulmonary embolism trial
penumbra
Penumbra launches Ruby XL coil system for large vessel embolization
Penumbra (NYSE:PEN) has received FDA clearance and launched its Ruby XL system for embolization procedures. The Alameda, California-based device maker launched the platform as a new option for physicians treating high-flow or large-vessel cases. The Ruby XL system includes three new coils that are compatible with 0.035-inch diagnostic catheters … [Read more...] about Penumbra launches Ruby XL coil system for large vessel embolization
Penumbra has positive data for computer-assisted vacuum thrombectomy system
Penumbra (NYSE:PEN) today announced new data demonstrating improved outcomes with its computer-assisted vacuum thrombectomy (CAVT) technology. Data evaluated the use of the CAVT technology in people with intermediate-risk pulmonary embolism (PE). Results showed that those treated with CAVT had shorter hospital stay lengths, shorter … [Read more...] about Penumbra has positive data for computer-assisted vacuum thrombectomy system
Penumbra wins CE mark for computer-assisted thrombectomy tech
Penumbra (NYSE:PEN) announced today that it received CE mark approval for its computer-assisted vacuum thrombectomy (CAVT) technologies. The Lightning Flash 2.0 and Lightning Bolt 7 offerings from the Alameda, California-based company both picked up European approval. Penumbra said approval makes its Lightning products the only CAVT systems … [Read more...] about Penumbra wins CE mark for computer-assisted thrombectomy tech
Penumbra announces $200M share repurchase program
Penumbra (NYSE:PEN) announced today that its board of directors approved a share repurchase authorization of up to $200 million. Alameda, California-based Penumbra said in a news release that its board approved the repurchase on Aug. 5. It allows the company to repurchase its common stock from time to time at such prices as it deems appropriate. … [Read more...] about Penumbra announces $200M share repurchase program
Penumbra launches duo of stroke catheters in Europe
Penumbra (NYSE:PEN) announced today that, with CE mark approval, it launched its new BMX81 and BMX96 neuro access devices in Europe. The company designed the devices for the neurovascular management of ischemic and hemorrhagic stroke. Penumbra said they represent its "most advanced neuro access offerings," according to a news release. The launch … [Read more...] about Penumbra launches duo of stroke catheters in Europe
FDA clears computer-assisted thrombectomy system from Penumbra
Penumbra (NYSE:PEN) announced today that it received FDA clearance for and began the launch of its Lightning Flash 2.0 CAVT system. Lightning Flash 2.0 represents the next generation of the company's computer-assisted vacuum thrombectomy (CAVT) technology. It removes the venous thrombus to treat pulmonary emboli (PE). The system features … [Read more...] about FDA clears computer-assisted thrombectomy system from Penumbra
First patient enrolled in Penumbra study of computer-assisted vacuum thrombectomy
Penumbra (NYSE:PEN) today announced the first patient enrolled in STORM-PE, a trial of its Lightning Flash thrombectomy system. Lightning Flash, a mechanical thrombectomy system, received FDA clearance in January. The system features Penumbra’s novel Lightning intelligent aspiration technology with dual-clot detection algorithms. Combining it … [Read more...] about First patient enrolled in Penumbra study of computer-assisted vacuum thrombectomy
The top catheter innovation news stories of 2023 — so far
The world of catheter innovation has already seen remarkable strides this year— with some of the most promising medtech delivered into the body via catheter-based procedures. Think of improved ablation for treating AFib, coronary intravascular lithotripsy to combat coronary artery disease, and more. Here, we've highlighted the top five … [Read more...] about The top catheter innovation news stories of 2023 — so far
How Penumbra’s smart-sucking algorithms and catheters speed up clot removal
Blood loss is a big problem when using aspiration catheters to remove blood clots from patients' veins and arteries. "You suck out the clot, you also suck out the blood," said Sandra Lesenfants, president of the interventional business at Penumbra (NYSE:PEN). Algorithms developed by Penumbra's software team for the company's continuous … [Read more...] about How Penumbra’s smart-sucking algorithms and catheters speed up clot removal
